Bayer targets mid-20% EBITDA margin and above-market growth by 2029
Bayer says it is targeting above-market growth and a mid-20% CEBITDA margin by 2029, citing progress in margin, sales and cash flow initiatives.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.